ARAY Accuray Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ARAY

Price (delayed)

$0.2672

Market cap

$31.91M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.4

Enterprise value

$167.02M

?
Relative Growth: Rel. Growth: 3
Relative Strength: Rel. Strength: 3
Relative Valuation: Rel. Valuation: 41
Relative Profitability: Rel. Profitability: 11

Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions that are designed to deliver radiation treatments ...

Highlights
The quick ratio has declined by 19% year-on-year but it has increased by 15% since the previous quarter
The gross margin has declined by 14% year-on-year but it has increased by 3.4% since the previous quarter
ARAY's equity is down by 49% YoY
The company's gross profit fell by 24% YoY and by 3% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://www.accuray.com
Peers: SYK

Key stats

What are the main financial stats of ARAY

ARAY stock price

How has the Accuray stock price performed over time
Intraday
2.77%
1 week
1.95%
1 month
-0.96%
1 year
-81.7%
YTD
-67.6%
QTD
3.65%

Financial performance

How have Accuray's revenue and profit performed over time
Revenue
$401.95M
Gross profit
$111.45M
Operating income
-$26.44M
Net income
-$49.19M
Gross margin
27.7%
Net margin
-12.2%
The company's gross profit fell by 24% YoY and by 3% QoQ
The gross margin has declined by 14% year-on-year but it has increased by 3.4% since the previous quarter
Accuray's net margin has decreased by 13% QoQ
Accuray's revenue has decreased by 12% YoY and by 6% from the previous quarter

Price vs fundamentals

How does ARAY's price correlate with its fundamentals

Growth

What is Accuray's growth rate over time

Valuation

What is Accuray stock price valuation
ARAY P/E details
P/E
N/A
P/B
0.76
P/S
0.08
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.42
The EPS has contracted by 8% from the previous quarter
The price to book (P/B) is 83% lower than the 5-year quarterly average of 4.3 and 56% lower than the last 4 quarters average of 1.7
ARAY's equity is down by 49% YoY
The price to sales (P/S) is 84% lower than the 5-year quarterly average of 0.5 and 60% lower than the last 4 quarters average of 0.2
Accuray's revenue has decreased by 12% YoY and by 6% from the previous quarter

Efficiency

How efficient is Accuray business performance
Accuray's ROE has decreased by 28% from the previous quarter
The company's return on assets fell by 9% QoQ
The ROIC has increased by 4.3% QoQ

Dividends

What is ARAY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ARAY.

Financial health

How did Accuray financials performed over time
The company's total assets is 10% higher than its total liabilities
The quick ratio has declined by 19% year-on-year but it has increased by 15% since the previous quarter
Accuray's current ratio has decreased by 9% YoY but it has increased by 6% QoQ
The company's debt to equity has surged by 103% YoY
ARAY's equity is down by 49% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.